Dr. Moore is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
945 N 5th Street
Albemarle, NC 28001
Education & Training
Brown UniversityFellowship, Hematology and Medical Oncology, 1998 - 2001
University of Mississippi Medical CenterResidency, Internal Medicine, 1996 - 1998
University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1995 - 1996- University of Mississippi School of MedicineClass of 1995
Certifications & Licensure
NC State Medical License 2009 - 2025
AL State Medical License 2006 - 2009- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer Start of enrollment: 2011 Apr 07
Publications & Presentations
PubMed
- 26 citationsp53 mutations do not predict response to paclitaxel in metastatic nonsmall cell lung carcinoma.Thomas King, Wallace Akerley, Alice C. Fan, Todd Moore, Shamlal Mangray
Cancer. 2000-08-15 - 1 citationsUpdate in non-small cell lung cancer.Todd Moore, Neal Ready
Medicine and Health, Rhode Island. 2002-01-01
Press Mentions
Local Cancer Survivor Encourages Early Screening as Part of National Colorectal Cancer Awareness MonthMarch 6th, 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
